Skip to main content

Table 2 Hemodynamic parameters at rest and during hyperemia in healthy controls and type 2 diabetic patients

From: Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine

 

Controls (n = 10)

T2DM patients (n = 26)

P

Heart rate, beats min−1

 Rest

55 ± 3

64 ± 11

<0.01

 Hyperemia

76 ± 10

79 ± 13

0.42

 P-value

<0.01

<0.01

 

Systolic blood pressure, mmHg

 Rest

116 ± 6

127 ± 17

0.01

 Hyperemia

129 ± 11

131 ± 19

0.68

 P-value

<0.01

0.12

 

Diastolic blood pressure, mmHg

 Rest

71 ± 6

66 ± 10

0.26

 Hyperemia

74 ± 6

67 ± 8

0.02

 P-value

0.21

0.47

 

Mean arterial pressure, mmHg

 Rest

86 ± 5

87 ± 12

0.72

 Hyperemia

92 ± 5

89 ± 11

0.17

 P-value

0.02

0.23

 

Rate pressure product, mm Hg min−1

 Rest

6318 ± 515

8050 ± 1430

<0.01

 Hyperemia

9673 ± 1123

10,355 ± 2217

0.23

 P-value

<0.01

<0.01

 
  1. Data are mean ± SD
  2. T2DM type 2 diabetes mellitus